Healey & AMG Center for ALS Launches ALS MyMatch: an Early Phase Biomarker Driven Trial Program
Healey & AMG Center for ALS Launches ALS MyMatch: an Early Phase Biomarker Driven Trial Program
Healey Center News & Events
Narrow your search for a specific article by using the search box and/or filters.
98 results
From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen
From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen. From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen. We are excited to be expanding our network of ALS researchers and the impactful work being done across our
Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with Fosigotifator
Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with Fosigotifator
Sean M. Healey & AMG Center Announces Topline Results in HEALEY ALS Platform Trial with eIF2B Agonist DNL343
Sean M. Healey & AMG Center Announces Topline Results in HEALEY ALS Platform Trial with eIF2B Agonist DNL343
University of Minnesota, Essentia Health Dose First Participants in Sean M. Healey & AMG Center for ALS, Never Surrender Inc. Led Expanded Access Protocol Programs
University of Minnesota, Essentia Health Dose First Participants in Sean M. Healey & AMG Center for ALS, Never Surrender Inc. Led Expanded Access Protocol Programs
Sean M. Healey & AMG Center Announces Updates to HEALEY ALS Platform Trial Master Protocol
Sean M. Healey & AMG Center Announces Updates to HEALEY ALS Platform Trial Master Protocol
Healy Center for ALS Presents the Lalji Award for Innovative Healing
The Sean M. Healey & AMG Center for ALS awards the fourth annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing to Richard Robitaille, Ph.D.
Healy Center Awards Innovation Prize to BrainGate Team
Sean M. Healey & AMG Center for ALS at Mass General awards sixth annual Sean M. Healey International Prize for Innovation in ALS to Leigh Hochberg, M.D., Ph.D. & the BrainGate Consortium Team
How the Healey ALS Platform Trial is Helping to Accelerate the Pathway to New ALS Treatments
Sabrina Paganoni, MD, PhD, speaks about the HEALEY ALS Platform Trial, a novel approach to testing new therapeutics for ALS patients.
From the Bench- The Lab of Dr. Mark Albers at Massachusetts General Hospital
In this issue, we highlight research updates from the Albers Lab at Massachusetts General Hospital. The Albers lab combines chemical biology, genetics, and computational methods in human brain tissue and mouse models to understand how neurodegenerative diseases develop.
Showing 1 - 10 of 98 results
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.